#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ocular lymphoma Sarcoma Follicular lymphoma Progressive supranuclear palsy Kawasaki's disease Small for dates baby Adenocarcinoma gastric Myelodysplastic syndrome Astrocytoma Cataract Dent's disease Angiosarcoma non-metastatic Warm autoimmune haemolytic anaemia Peritoneal mesothelioma malignant Idiopathic intracranial hypertension More trials…

    Learn about Rare Diseases

    Von Willebrand’s disease Myelodysplastic syndrome with excess blasts – Diagnostics Metachromatic leukodystrophy – Trials in Disease Ewing’s sarcoma metastatic Congenital generalised lipodystrophy – Basic Information Fabry’s disease Idiopathic pulmonary fibrosis – Trials in Disease IgA nephropathy – Trials in Disease Hepatic angiosarcoma – Basic Information Adrenogenital syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dersimelagon Phosphate Abc-35B-116 Melphalan Hydrochloride Iopromide Simvastatin METHYLPHENIDATE Vemircopan Specific Nucleic Acid Sna-Xfsb Bictegravir Salbutamol Sulfate Ph. Eur. Vh4524184 Azd7798 Al8326 MAPLIRPACEPT INCB123667 Faricimab Threonine Pentetic Acid LY3848575 Etoricoxib More therapies…

    Learn about Your Condition

    Desmoplastic melanoma Toxic nodular goitre Endocarditis enterococcal Restless legs syndrome Hepatic cancer Anaplastic thyroid cancer Vaginal haemorrhage Cerebral amyloid angiopathy Neuromuscular scoliosis Electronic cigarette user Amnestic disorder KBG syndrome Pulmonary resection Frontotemporal dementia Deep vein thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Migraine

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Isosorbide Dinitrate
    • SUMATRIPTAN
    • Rimegepant
    Spain

  • Study on Ethinylestradiol/Levonorgestrel and Vitamin E for Treating Menstrual and Perimenopausal Migraines in Women

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alpha-Tocopherol
    • Ethinylestradiol
    • Levonorgestrel
    The Netherlands

  • Study on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Rimegepant
    France Italy Poland Spain

  • Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Italy Poland Portugal Spain

  • Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

    Recruiting

    2 1
    Investigated Drugs:
    • Medi0618
    Czechia Denmark Germany Hungary Italy The Netherlands +2

  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Eptinezumab
    Italy Poland Portugal Spain
Previous Page
1 2 3 4 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!